Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S SHALDON

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Kidney International. Supplement|June 1, 1993
Unanswered questions pertaining to dialysis adequacy in 1992S Shaldon
Current Opinion in Nephrology and Hypertension|December 1, 1992
Adequacy of long-term hemodialysisS Shaldon
Clinical Nephrology|January 1, 1986
Future trends in biocompatibility aspects of hemodialysis and related therapiesS Shaldon
Life Support Systems : the Journal of the European Society for Artificial Organs|October 1, 1987
The relationship between biocompatibility and interleukin-1S Shaldon, C A Dinarello
Artificial Organs|May 1, 1995
Biocompatibility in hemodialysis: clinical relevance in 1995S Shaldon, K M Koch
Clinical Nephrology|February 1, 1978
The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patientsA Mimran, S Shaldon, P Barjon, et al.
Clinical Nephrology|December 1, 1991
Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover studyC Granolleras, W Leskopf, S Shaldon, et al.
The International Journal of Artificial Organs|February 1, 1990
Hemodialysis-related induction of beta 2-microglobulin synthesis and release by mononuclear phagocytesP J Knudsen, S Shaldon, J Floege, et al.
Kidney International. Supplement|October 1, 1992
Dialysis related amyloidosis: a disease of chronic retention and inflammation?J Floege, J Schäffer, K M Koch, et al.
Clinical Nephrology|July 2, 2003
Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogensR Schindler, F Christ-Kohlrausch, U Frei, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Kidney International. Supplement|June 1, 1993
Unanswered questions pertaining to dialysis adequacy in 1992S Shaldon
Current Opinion in Nephrology and Hypertension|December 1, 1992
Adequacy of long-term hemodialysisS Shaldon
Clinical Nephrology|January 1, 1986
Future trends in biocompatibility aspects of hemodialysis and related therapiesS Shaldon
Life Support Systems : the Journal of the European Society for Artificial Organs|October 1, 1987
The relationship between biocompatibility and interleukin-1S Shaldon, C A Dinarello
Artificial Organs|May 1, 1995
Biocompatibility in hemodialysis: clinical relevance in 1995S Shaldon, K M Koch
Clinical Nephrology|February 1, 1978
The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patientsA Mimran, S Shaldon, P Barjon, et al.
Clinical Nephrology|December 1, 1991
Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover studyC Granolleras, W Leskopf, S Shaldon, et al.
The International Journal of Artificial Organs|February 1, 1990
Hemodialysis-related induction of beta 2-microglobulin synthesis and release by mononuclear phagocytesP J Knudsen, S Shaldon, J Floege, et al.
Kidney International. Supplement|October 1, 1992
Dialysis related amyloidosis: a disease of chronic retention and inflammation?J Floege, J Schäffer, K M Koch, et al.
Clinical Nephrology|July 2, 2003
Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogensR Schindler, F Christ-Kohlrausch, U Frei, et al.
Pageof 6